No. KPV is not approved for any use, in any form. In July 2026 an FDA advisory panel recommended it for the 503A compounding bulks list — an advisory recommendation in a pending rulemaking that's moving toward broader legitimate access, not approval or a finding of efficacy.

What does KPV do in the body?

In cell and animal models, KPV is transported into cells by the PepT1 peptide transporter and inhibits NF-κB and MAPK inflammatory signaling. Whether any of that happens in humans, at any dose, from any consumer product, is unknown — there are no human clinical trials to answer it yet.

Why is KPV sold in blends instead of by itself?

In this catalog, KPV exists only inside the KLOW blend (with BPC-157, TB-500, and GHK-Cu). That's partly a demand question — KPV interest is mostly educational — and partly a formulation one: KPV ships as part of the KLOW blend rather than as a standalone strip.

Can you absorb KPV from a dissolving strip?

Nobody has published a measurement. KPV is a very small molecule and showed oral activity in mouse models, making it scientifically plausible as an oral-format candidate — but no human absorption data exists for KPV in any consumer format. Any brand quoting an absorption percentage is quoting a number that doesn't exist in the literature.

What Is KPV Peptide? An alpha-MSH Fragment

Short answer: KPV is a tiny three-amino-acid peptide — lysine, proline, valine — the tail end of a hormone your own body makes called alpha-MSH. Researchers found that alpha-MSH's inflammation-calming signaling appears to live in those last three amino acids. In our catalog you will find it inside the KLOW blend.

KPV is one of the most-asked-about compounds in the gut-health corner of the peptide world, and the curiosity is well-placed: this is a molecule small enough to ride the body's own peptide transporter into intestinal cells — a delivery story built into the molecule itself. This page is the reference our other KPV content links back to: what it is, why people are excited about it, what the research has explored, and why it lives inside a blend here.

What KPV actually is

KPV is a tripeptide — a chain of just three amino acids: lysine (K), proline (P), valine (V). KPV is the C-terminal fragment of alpha-melanocyte-stimulating hormone (alpha-MSH), a 13-amino-acid peptide your own body produces, studied for decades for its role in inflammatory signaling.

The elegant part: researchers found that the anti-inflammatory signaling activity of alpha-MSH appears concentrated in those last three amino acids — and KPV doesn't appear to work through the melanocortin receptors behind alpha-MSH's other effects, which is why it doesn't carry the pigmentation effects the parent hormone is known for. [preclinical evidence]

A few things to be precise about:

It is a fragment, not the whole hormone. Findings about alpha-MSH don't automatically transfer to KPV, and vice versa.
It is not an approved medicine. Not in the US, not anywhere, for any use.
It is one of the smallest peptides in this category. At three amino acids (~341 daltons), it is dramatically smaller than BPC-157 (15 amino acids) or TB-500's parent protein — and small is exactly what oral delivery routes love.

Why people are excited about it

KPV's fan base is the gut-health community, and the excitement traces to a real scientific story: a peptide whose own transporter — PepT1 — ferries it into intestinal cells. Search around peptide communities and KPV almost always appears in the same conversations as BPC-157 and TB-500 — the three are the core of what the community calls gut-and-recovery stacks.

Here's what people actually ask (questions and curiosity, because that's what genuinely drives the searches):

whether KPV's gut-focused preclinical research complements BPC-157's (BPC-157's own origin story is gastric, and users frequently ask how the two compare) [preclinical evidence]
whether a tiny tripeptide survives digestion better than larger peptides — a real scientific question, and the size logic is genuinely in KPV's favor
why the three are sold together in blends like KLOW, which combines BPC-157, TB-500, GHK-Cu, and KPV in a single strip

What the research has explored

Almost everything published about KPV is preclinical — cell cultures and animal models — and the most-cited line of research centers on inflammatory signaling in the intestine:

A widely cited 2007 study (Dalmasso et al., Gastroenterology, PMC2431115) reported that KPV was transported into intestinal epithelial and immune cells by the peptide transporter PepT1, and that nanomolar concentrations inhibited NF-κB and MAP kinase inflammatory signaling in those cells. In mouse models of induced colitis, orally administered KPV (given in drinking water) reduced inflammatory markers and histological signs of inflammation in the animals — the oral-activity finding that put KPV on the delivery-format map. [preclinical evidence]
Related preclinical work has examined KPV in skin and airway cell models, again through the lens of inflammatory signaling pathways like NF-κB. [preclinical evidence]

To be precise about scope: scientists studying KPV in intestinal inflammation models is a statement about the literature, not a claim that any product treats anything. But as preclinical stories go, this one is coherent, mechanistically specific, and genuinely interesting.

Regulatory momentum — moving the right direction

KPV is not FDA-approved for any use, in any form — so no product containing it can claim to treat, cure, or prevent anything. But in July 2026, an FDA Pharmacy Compounding Advisory Committee panel reviewed KPV and recommended it for inclusion on the 503A bulks list of substances compounding pharmacies may use. The recommendation is advisory and non-binding, rulemaking is pending, and the direction of travel is toward more legitimate access for this category. We'll update this page as the rulemaking develops.

The honest context

Here's the passage that doesn't help us sell, kept anyway: there are essentially no human clinical trials of KPV — no randomized controlled studies, no established human dose, no long-term safety data, and no published measurement of KPV absorption from an oral dissolving strip. Oral activity in a mouse gut model is not measured absorption in a human, and nobody has shown the mouse-model findings transfer to people. If you have an actual gut condition — pain, bleeding, a diagnosis, or symptoms you're worried about — a peptide strip is not the answer; the answer is a licensed clinician and evidence-based care. Adults 18+ only, never while pregnant or nursing, and talk to a healthcare provider before adding any new product.

Why KPV is blend-only in this catalog

We don't carry a standalone KPV product — KPV appears in our catalog in exactly one place: the KLOW four-peptide blend, alongside BPC-157, TB-500, and GHK-Cu, 20 oral dissolving strips per box.

Two reasons for that routing honesty. First, KPV's search interest is almost entirely educational — people want to know what it is and whether the research is real. Second, KLOW is available at open checkout. One more disclosure of our own: KLOW is one of the SKUs in the InstaMed line that currently has no COA on file — its third-party testing status is unverified, and we say so rather than imply otherwise.

The strips we carry are sold under the InstaMed brand (Salt Lake City/Draper, Utah); we sell them as an authorized reseller.

The bottom line

KPV is three amino acids with a beautifully specific mechanism story — the inflammation-signaling fragment of your own alpha-MSH, small enough to ride the body's own peptide transporter, and studied in exactly the gut models the community cares about. The research is early but coherent, the regulatory tide is turning its way, and the needle-free route in is KLOW. Order, keep learning, and bring your provider into the conversation — that's how this category is done well.

---

Explore this cluster

The rest of the KPV file: what the research has explored, the safety picture, and why its size makes the sublingual route unusually sensible.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

This content is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any new product. Individual results vary.

What Is KPV? The alpha-MSH Fragment Explained